Nearly one year after its introduction to the House of Commons, the Medicines and Medical Devices Bill 2019‑2021 (the Bill) was granted Royal Assent on 11 February 2021, becoming law as the Medicines and Medical Devices Act...more
2/25/2021
/ Clinical Trials ,
Criminal Sanctions ,
EU ,
Life Sciences ,
Medical Devices ,
Medical Technology Companies ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
Pharmaceutical Industry ,
Trade Agreements ,
UK ,
UK Brexit ,
UK Parliament
In our Quarterly Review, we bring you important UK developments relating to business crime, investigations, and regulatory enforcement from the last three months. Please contact us if you would like to discuss any of these...more
12/15/2020
/ Anti-Corruption ,
Bribery ,
British Airways ,
Criminal Investigations ,
Deferred Prosecution Agreements ,
Financial Conduct Authority (FCA) ,
FSCS ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
Memorandum of Understanding ,
Modern Slavery Act ,
National Crime Agency (NCA) ,
Office of Financial Sanctions Implementation (OFSI) ,
Popular ,
Serious Fraud Office (SFO) ,
Task Force on Climate-related Financial Disclosures (TCFD) ,
Trafficking ,
UK ,
UK Bribery Act
As Brexit is finally completed in the UK, from 1 January 2021, the Medicines and Healthcare products Regulatory Agency (“MHRA”) will be the UK’s standalone medicines and medical devices regulator. Transition from the EU...more